Real-World Evidence in Medicine Development Course starts October 2nd

Monday, 4 September 2017

This is an interactive online course, which is aimed at anyone interested in knowing more about opportunities and challenges for the use of real-world evidence in medicine development. It is an ideal resource for anyone who wishes to become familiar with the key issues in the areas of real-world data and wishes to broaden his/her expertise. The aim of the course is to facilitate discussion, interaction and mutual learning across all professionals involved in medicine development.

One of the sections of the modules is dedicated to stakeholders’ perspectives about the use of real-world data in medicines development.By taking part in the interactive course, you will be able to amplify the patient voice to ensure it is heard by other attendees.

Course participants will come from pharmaceutical companies, regulatory authorities, HTA bodies, patients’ organisations, consultancy companies and academia. As such, the course will foster discussion, interaction and mutual learning across all professionals involved in medicine development.

At the end of the course, you will be able to:

  • Describe the medicine development chain and perspectives of various stakeholders on this chain
  • Explain the factors that may affect the effectiveness of a new medicine in real life
  • Explain existing designs for efficacy and effectiveness studies and how to evaluate those
  • Explain the relationship between the study design choices of a relative effectiveness study and the value of information for marketing authorization at HTA
  • Describe the operational challenges (including ethical, regulatory and legal aspects) of relative effectiveness studies
  • Describe the existing current methods in evidence synthesis and the methods that can be applied for predictive medicine effectiveness modeling (incorporating real-world evidence)
  • Understand how to integrate thinking about real-world evidence into medicine development and decision-making
  • Communicate policy options around relative effectiveness, real-world evidence and various study designs

Click here to enroll on the course